Overview

Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. To Evaluate the therapeutic efficacy of cholic acid during provision of compassionate treatment to patients with identified inborn errors of bile acid synthesis and metabolism II. To assess the safety and tolerability of cholic acid
Phase:
Phase 3
Details
Lead Sponsor:
Retrophin, Inc.
Travere Therapeutics, Inc.
Collaborator:
Children's Hospital Medical Center, Cincinnati
Treatments:
Bile Acids and Salts
Cholic Acids